Item 5. Other Information
ITEM 5. OTHER INFORMATION
None of our directors or officers informed us of the adop tion or termi nation of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K, during the three-month period ended September 30, 2025.
45
Table of Contents
ITEM 6. EXHIBITS
Exhibit No.
Description
3.1
Second Amended and Restated Articles of Incorporation.*
3.2
Fourth Amended and Restated Bylaws.*
10.1
Chief Executive Officer Employment Agreement, dated October 3, 2025, by and between Merit Medical Systems, Inc. and Martha G. Aronson. †
10.2
Performance Stock Unit Award Agreement (Three Year Performance Period), dated October 3, 2025, by and between Merit Medical Systems, Inc. and Martha G. Aronson. †
10.3
Restricted Stock Unit Award Agreement, dated October 3, 2025, by and between Merit Medical Systems, Inc. and Martha G. Aronson. †
10.4
CEO Transition Agreement, dated October 3, 2025, by and between Merit Medical Systems, Inc. and Fred P. Lampropoulos. †
10.5
Employment Agreement, dated September 1, 2025, by and between Merit Medical Systems, Inc. and Christian Adam Smith. †
10.6
Indemnification Agreement, dated September 1, 2025, by and between Merit Medical Systems, Inc. and Christian Adam Smith. †
31.1
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .
31.2
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .
32.1
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 .
32.2
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 .
101
The following financial information from the quarterly report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) related Condensed Notes to the Unaudited Consolidated Financial Statements, tagged in detail.
104
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).
* These exhibits are incorporated herein by reference.
† Indicates management contract or compensatory plan or arrangement.
46
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MERIT MEDICAL SYSTEMS, INC.
Date: October 30, 2025
By:
/s/ MARTHA G. ARONSON
Martha G. Aronson
Chief Executive Officer and President
Date: October 30, 2025
By:
/s/ RAUL PARRA
Raul Parra
Chief Financial Officer and Treasurer
47